LMR Partners’s INmune Bio INMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-41,600
Closed -$96.1K – 1543
2025
Q2
$96.1K Buy
+41,600
New +$305K ﹤0.01% 1177

Other funds holding INMB

LMR Partners's INMB Position: Q3 2026 in Review

LMR Partners held its INmune Bio (INMB) position steady in Q3 2026 at 16,600 shares worth $32.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1519.

LMR Partners first reported a position in INMB in Q3 2025 and has held it in 5 quarters since. The position peaked at $34.4K in Q3 2025. 63 funds tracked by Wall St. Rank hold INMB as of Q3 2026.

  • LMR Partners held 16,600 shares of INmune Bio worth $32.4K as of Q3 2026.
  • LMR Partners left its INmune Bio share count unchanged in Q3 2026.
  • INmune Bio made up ﹤0.01% of LMR Partners's portfolio in Q3 2026, its #1519 holding.
  • LMR Partners first reported a position in INmune Bio in Q3 2025 and has held it in 5 quarters since.
  • LMR Partners's INmune Bio position peaked at $34.4K in Q3 2025.
  • 63 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.